Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Dare Bioscience, Inc.

NASDAQ: DAREHealthcare / Biotechnology / -
0.7800-0.0200-2.50%Vol 35 0891Y Perf -42.86%
Feb 15th, 2019 16:00
BID0.7800 ASK0.8000
Open0.8000 Previous Close0.8000
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.25 
Analyst Rating
Strong Buy 1.00
Potencial %
701.28 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)9 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
16.36 
Earnings Date
1st Apr 2019

Today's Price Range

0.78000.8400

 

52wk Range

0.60001.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-7.14%
3 Months
-16.13%
6 Months
-21.21%
1 Year
-42.86%
3 Years
-96.16%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
DARE0.7800-0.0200-2.50
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
8.00
Current Ratio
8.50
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-
EBITDA Margin
-
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.92
PS Ratios
-
Price to Cash Flow
-
Price to Free Cash Flow
-1.10
Cash Flow Per Share
-0.91
Price to Tangible Book
0.92
Book Value per Share
0.84
Enterprise Value (in ths.)
-702
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
451.21
ROE last 12 Months
-143.41
Return on Assets (5Y Avg)
-181.82
ROA last 12 Months
-134.77
Return on Capital (5Y Avg)
-116.41
ROC last 12 Months
-143.41
Return on invested Capital Q
-23.62
Return on invested Capital Y
-177.72
Assets Turnover
0.00
Receivables Turnover
0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
0
Revenue per Share
0.00
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.23-0.230.00
Q01 2018--0.28-
Q04 2017--0.49-
Q02 2017--1.42-
Q01 2017-3.10-2.2029.03
Q03 2016-4.30-3.6016.28
Q02 2016-4.80-4.0016.67
Q01 2016-4.20-4.90-16.67
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.28-16.67Negative
12/2018 FY-1.06-35.90Negative
3/2019 QR-0.3169.90Positive
12/2019 FY-1.22--
Next Report Date1st Apr 2019
Estimated EPS Next Report-0.28
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume35 089
Shares Outstanding (in ths.)11 422
Trades Count61
Dollar Volume27 536
Avg. Volume48 813
Avg. Weekly Volume58 626
Avg. Monthly Volume39 866
Avg. Quarterly Volume247 537

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

43%57%

Bearish Bullish

77%23%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News